Raputide 10 mg (Raputidine)

Adult dose

1. Short-term treatment of gastric ulcer The usual dose is 10 mg of lafutidine per dose, taken orally twice daily in the morning and at bedtime. In clinical trials of up to 8 weeks, most ulcers healed within 8 weeks, although healing time may vary in some patients. 2. Short-term treatment of duodenal ulcer The usual dose is 10 mg of lafutidine per dose, taken orally twice daily in the morning and at bedtime. In clinical trials of up to 6 weeks, most ulcers healed within 6 weeks, although healing time may vary in some patients. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis The usual dose is 10 mg of lafutidine once daily, taken orally at bedtime. In clinical trials of up to 2 weeks, most lesions healed within 2 weeks, although healing time may vary in some patients. 4. Antibiotic combination therapy for patients with peptic ulcer infected with Helicobacter pylori Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication for anesthesia The usual dose is 10 mg of lafutidine per dose, taken orally twice (at bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis Administer 10 mg of lafutidine per dose orally twice daily.

This medicine should not be used by patients who are allergic to any of its ingredients. This medicine contains lactose, so patients with genetic diseases that prevent lactose digestion should also avoid using it. Patients with a history of hypersensitivity to the drug, liver or kidney dysfunction, those undergoing dialysis, and elderly patients should use this medicine with caution. This medicine may rarely cause severe allergic reactions or liver dysfunction, so if symptoms such as facial pallor, low blood pressure, or difficulty breathing occur, usage should be stopped immediately and medical advice should be sought. Regular monitoring is necessary as liver function tests may show elevated levels or signs of jaundice. Serious side effects such as agranulocytosis and thrombocytopenia may occur, so if unusual symptoms such as sore throat, general malaise, or fever appear, notify a doctor immediately. During the course of this medication, serious side effects such as skin rash, convulsions, and cardiac arrhythmias have been reported, so attention is required. Gastrointestinal symptoms may include constipation, diarrhea, nausea, vomiting, abdominal bloating, and loss of appetite. Central nervous system symptoms reported include headache, insomnia, drowsiness, confusion, hallucinations, altered consciousness, and dizziness. Circulatory symptoms may include cold extremities or facial flushing. Blood tests may reveal increased or decreased white blood cells or red blood cells, and liver function tests may also show elevated levels. Renal-related side effects such as kidney dysfunction or increased serum uric acid levels should also be monitored. This medication is used for patients with gastric ulcers or gastroesophageal reflux disease, and if there is no therapeutic effect, alternative treatments should be considered. If malignant tumors are suspected, professional examination must be completed before using this medication, and the use should be discontinued if diagnosed with malignant gastric cancer. Elderly patients may have decreased bodily function, so dosage and administration intervals should be adjusted, using the medication carefully. Dialysis patients may experience increased plasma drug concentrations, so dosing should start at low levels and be administered with care. Pregnant women should use this medication only if the benefits outweigh the risks under medical supervision, and breastfeeding women should avoid using this medication due to excretion into breast milk. The safety for pediatric use has not been established, so use should be cautious. This medication should be kept out of the reach of children and stored in its original container, avoiding transfer to other containers. Carcinogenicity was not observed in animal experiments, although some endocrine cell hyperplasia was noted at high doses, and certain reproductive toxicity was observed without teratogenicity reported.

• Shock
• anaphylaxis symptoms
• facial pallor
• hypotension
• generalized rash
• respiratory distress
• liver function impairment
• jaundice
• pharyngodynia
• general malaise

This medicine should be stored in a tightly closed container to protect it from air and moisture and is best kept at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy for a long time.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle